COVID – 19 | Vaccination Update – Day 480

ad
Measles Rubella vaccination 2nd phase campaign rolled out
Vaccination

India’s COVID-19 vaccination coverage has crossed 190.65 Crore (1,90,65,51,885today. More than 12 lakh (12,95,705) Vaccine Doses have been administered till 7 pm today. The daily vaccination tally is expected to increase with the compilation of the final reports for the day by late tonight.

The cumulative coverage of vaccine doses, segregated based on population priority groups, is as follows:

Cumulative Vaccine Dose Coverage
HCWs 1st Dose 10405912
2nd Dose 10026104
Precaution Dose 4963198
FLWs 1st Dose 18417153
2nd Dose 17558647
Precaution Dose 8024258
Age Group 12-14 years 1st Dose 30880463
2nd Dose 10619800
Age Group 15-18 years 1st Dose 58807044
2nd Dose 43426174
Age Group 18-44 years 1st Dose 556351829
2nd Dose 482874579
Precaution Dose 317035
Age Group 45-59 years 1st Dose 203079287
2nd Dose 189183809
Precaution Dose 861126
Over 60 years 1st Dose 126979565
2nd Dose 117901681
Precaution Dose 15874221
Cumulative 1st dose administered 1004921253
Cumulative 2nd dose administered 871590794
Precaution Dose 30039838
Total 1906551885

 

Today’s achievement in the vaccination exercise, segregated by population priority groups, is as follows:

Date: 10th April, 2022 (480th Day)
HCWs 1st Dose 31
2nd Dose 496
Precaution Dose 12023
FLWs 1st Dose 105
2nd Dose 1219
Precaution Dose 31741
Age Group 12-14 years 1st Dose 161938
2nd Dose 339850
Age Group 15-18 years 1st Dose 28159
2nd Dose 87598
Age Group 18-44 years 1st Dose 36305
2nd Dose 330081
Precaution Dose 13805
Age Group 45-59 years 1st Dose 8535
2nd Dose 78147
Precaution Dose 24671
Over 60 years 1st Dose 5242
2nd Dose 51296
Precaution Dose 84463
Cumulative 1st dose administered 240315
Cumulative 2nd dose administered 888687
Precaution Dose 166703
Total 1295705

 

The vaccination exercise as a tool to protect the most vulnerable population groups in the country from COVID-19 continues to be regularly reviewed and monitored at the highest level.

Be the first to comment

Leave a Reply

Your email address will not be published.


*